Intiva BioPharma Inc.·4

Sep 4, 5:04 PM ET

Snider Lindy 4

4 · Intiva BioPharma Inc. · Filed Sep 4, 2018

Insider Transaction Report

Form 4
Period: 2018-08-08
Snider Lindy
Director
Transactions
  • Other

    Class C Warrants (right to buy)

    2018-08-0840,0000 total
    Exercise: $0.50From: 2017-11-29Exp: 2018-08-08Common Stock (40,000 underlying)
  • Other

    Class D Warrants (right to buy)

    2018-08-08+40,00040,000 total
    Exercise: $1.00From: 2018-08-08Exp: 2018-09-28Units (40,000 underlying)
Holdings
  • Stock option - right to buy

    Exercise: $0.54From: 2018-07-25Exp: 2023-07-25Common Stock (100,000 underlying)
    100,000
  • Common Stock

    480,000
Footnotes (3)
  • [F1]25,000 options vested immediately, with the remainder vesting quarterly over the next 6 quarters beginning with the quarter ending September 30, 2018.
  • [F2]Each unit consists of one share of common stock and one Class E Warrant.
  • [F3]Class C Warrants were exchanged for an equal number of Class D Warrants.

Documents

1 file
  • 4
    marketforms-42823.xmlPrimary

    PRIMARY DOCUMENT